Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 61Gastrointestinal 20Genitourinary 13Thoracic 12Plasma cell 9Lymphoid 7Head & Neck 7CNS 5Tumor-Agnostic 3Other 3Gynecologic 3Other hematologic neoplasm 2Sarcoma 1NET 1Myeloid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma 1Febrile Neutropenia 1Cross Infection 1

Interventions

Cyclophosphamide 93fludarabine phosphate 86Busulfan 63Cyclosporine 57Peripheral Blood Stem Cell Transplantation 54Mycophenolic Acid 54Whole-Body Irradiation 53Epoetin Alfa 53Antilymphocyte Serum 43fludarabine 42Filgrastim 41Cytarabine 41Tacrolimus 39Melphalan 38Darbepoetin alfa 38Methotrexate 34Radiotherapy 32Cord Blood Stem Cell Transplantation 28Granulocyte Colony-Stimulating Factor 23Methylprednisolone 21Etoposide 21apixaban 18eltrombopag 16Thiotepa 16Dalteparin 16ferric carboxymaltose 14Daunorubicin 14Azacitidine 14Alemtuzumab 14thymoglobulin 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Acupuncture Therapy × Classical hematology × Clear all
NCT06500715 2026-04-29

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Shaare Zedek Medical Center

Phase NA Not yet recruiting
60 enrolled
Classical hematologySarcoma

Cross Infection, Sarcoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡